A vaccine for the lethal Nipah virus, developed by the University of Oxford, has commenced phase two trials in Bangladesh.
Thirty-one healthy adults aged 18 to 55 will take part in the trial in Oxford, while a second phase-1 trial is expected to ...
Lassa fever is a priority pathogen in urgent need of research and development because it poses a significant public health ...
The trial, conducted in Bangladesh in partnership with the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), and funded by ...
In 1897, amid growing resistance across the UK, angry residents took to the streets of Charlbury in a protest that turned so chaotic it was said to have helped bring about a change in the law. Radio ...
A child receives a dose of polio vaccine during a door-to-door vaccination campaign in Karachi on September 9 - Copyright AFP Rizwan TABASSUM A child receives a dose ...
The University of Oxford has commenced the world’s first Phase II clinical trial of a Nipah virus vaccine candidate in Bangladesh, with the doses manufactured by Pune-based Serum Institute of India ...
The first human has been vaccinated with Oxford University's new Lassa fever vaccine in a major first‑in‑human trial ...
The Punch on MSN
First volunteer receives Lassa fever vaccine
The first volunteer has received a dose in a first-in-human trial of Oxford's Lassa fever vaccine, a major milestone in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results